Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takahashi Tohru is active.

Publication


Featured researches published by Takahashi Tohru.


Archive | 2004

Anti-human Fas antibodies, process of their preparation, host cell and composition

Serizawa Nobufusa; Ichikawa Kimihisa; Ohsumi Jun; Ohtsuki Masahiko; Haruyama Hideyuki; Takahashi Tohru; Yoshida Hiroko; Shiraishi Akio; Yonehara Shin


Archive | 2004

Polynucleotide sequence, DNA, polypeptide, pharmaceutical composition, vector, host, expression system, antibody, protein purification process and hybridoma

Takahashi Tohru; Koishi Ryuta; Kawashima Ichiro; Serizava Nobufusa


Archive | 2004

Polynucleotide sequence, DNA vector containing thereof, host, expressive system containing such vector, polypeptide, fusion protein, process for preparing the polynucleotide sequence, and use thereof

Takahashi Tohru; Koishi Ryuta; Kawashima Ichiro; Serizava Nobufusa


Archive | 2001

Anti-Fas antibodies capable of inducing apoptosis in cells with abnormality in the Fas/Fas ligand system

Serizawa Nobufusa; Haruyama Hideyuki; Nakahara Kaori; Takahashi Tohru; Tamaki Ikuko


Archive | 2001

Humanized molecule of the type of antibody against FAS, molecule of the antibody type with selected one or plurality of heavy and light chains, prophylactic and therapeutic preparation, DNA encoding antibody, recombinant DNA vector, transformed host cell, process for preparing antibody against FAS, transformation strain Escherichia coli, polypeptide, encoding DNA, recombinant DNA vector and transformed host cell thereof

Serizawa Nobufusa; Haruyama Hideyuki; Nakahara Kaori; Tamaki Ikuo; Takahashi Tohru


Archive | 2000

Moléculam anticorpo,uso de uma molécula, dna, vetor de dna recombinante, célula hospedeira,microorganismo, processo para produzir um anticorpo agente para o tratamento ou profilaxia de condições atribuìveis a normalidades do sistema ligando fas/fas, uso de uma molécula e hibridoma.

Serizawa Nobufusa; Ichikawa Kimihisa; Ohsumi Jun; Ohtsuki Masahiko; Haruyama Hideyuki; Takahashi Tohru; Yoshida Hiroko; Shiraishi Akio; Yonehara Shin


Archive | 2000

Molécula tipo anticorpo anti-fas, humanizada, agente para a profilaxia e/ou tratamento de condições envolvendo uma anormalidade no sistema ligando fas/fas, uso de um anticorpo, dna, vetor de dna recombinante, célula hospedeira, processo para produzir um anticorpo anti-pas, cepa transformante de e.coli, e, polipeptìdeo.

Serizawa Nobufusa; Haruyama Hideyuki; Nakahara Kaori; Tamaki Ikuko; Takahashi Tohru


Archive | 2000

Processo para produção de um anticorpo humanizado e derivados do mesmo e de uma proteìna de imunoglobuilina e para tratamento de doença autoimune, anticorpo humanizado ou um derivado do mesmo, rna, vetor replicável e célula hospedeira.

Serizawa Nobufusa; Haruyama Hideyuki; Takahashi Tohru; Nasahara Kaori; Yonehara Shin


Archive | 1999

ANTIBODYS AGAINST FAS-ANTIGENE

Haruyama Hideyuki; Ichikawa Kimihisa; Ohsumi Jun; Ohtsuki Masahiko; Serizawa Nobufusa; Shiraishi Akio; Takahashi Tohru; Yonehara Shin; Yoshida Hiroko


Archive | 1998

HUMANISED ANTIBODIES EFFECTIVE AGAINST HUMAN FAS

Serizawa Nobufusa; Haruyama Hideyuki; Takahashi Tohru; Nakahara Kaori; Yonehara Shin

Collaboration


Dive into the Takahashi Tohru's collaboration.

Researchain Logo
Decentralizing Knowledge